{"id":181308,"name":"MALLINCKRODT PHARMACEUTICALS","slug":"mallinckrodt-pharmaceuticals","state":"MO","country":"United States of America","description":"Mallinckrodt Pharmaceuticals manufactures specialty products and diagnostics","totalSpending":1540000,"filings":20,"yearlySpending":[{"year":2018,"income":320000},{"year":2019,"income":320000},{"year":2020,"income":320000},{"year":2021,"income":320000},{"year":2022,"income":260000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","CHARLOTTE IVANCIC","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018","prescription drug abuse and deterrence, non-interference\nPL 114-255 - 21st Century Cures, implementation\nMulti-modal analgesics\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - ","H.R. 1- Tax Cuts and Jobs Act","prescription drug abuse and deterrence, non-interference\nPL 114-255 - 21st Century Cures, implementation\nMulti-modal analgesics\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - ","H.R. 1- Tax Cuts and Jobs Act"]}